AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Integrated CAncer GEnome Score (iCAGES) for personalized cancer therapy

Summary: This technology is an algorithm that leverages patient cancer genomic data to provide a personalized chemotherapy regimen.

Technology Benefits: Allows for personalized treatment plans specific to each patientRapidly analyzes patient-specific cancer genomic dataIdentifies cancer mutations to predict the best precision therapiesIncorporates treatments under clinical trials as options for therapy

Technology Application: Personalized cancer treatmentPredicting side effects of cancer treatments based on patient’s genomeAnalysis of existing cancer genomic data sets for determining treatment efficacyData collection for potential combination therapies

Detailed Technology Description: None

*Abstract: None

*Inquiry: Joan MartinezColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu

*IR: CU17137

*Principal Investigator

*Publications: Dong C, Guo Y, Yang H, He Z, Liu X, Wang K. “iCAGES: integrated Cancer Genome Score for comprehensively prioritizing driver genes in personal cancer genomes” Genome Med. 2016 Dec 22; 8(1): 1-22.Tech Ventures Reference:IR CU17137Licensing Contact: Joan Martinez

Country/Region: USA

For more information, please click Here